Thalomid

Active Ingredient(s): Thalidomide
FDA Approved: * July 16, 1998
Pharm Company: * CELGENE
Category: Cancer

Thalidomide, sold under the brand names Contergan, Thalomid among others, is a medication used to treat a number of cancers (including multiple myeloma), graft-versus-host disease, and a number of skin conditions including complications of leprosy.[3] While it has been used in a number of HIV-associated conditions, such use is associated with increased levels of the virus.[3] It is administered orally.[3] Common side effects include sleepiness,... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Thalomid 50 mg Oral Capsule
NDC: 59572-205
Labeler:
Celgene Corporation
Thalomid 100 mg Oral Capsule
NDC: 59572-210
Labeler:
Celgene Corporation
Thalomid 150 mg Oral Capsule
NDC: 59572-215
Labeler:
Celgene Corporation
Thalomid 200 mg Oral Capsule
NDC: 59572-220
Labeler:
Celgene Corporation